【正文】
10, .[ 16 ] David L. Deeds and Charles . Hill [1996], “Strategic alliances and the rate of new product development: an empirical study of entrepreneurial biotechnology firms.” Journal of Business Venturing, Vol. 11, No 3, pp. 4155.[ 17 ] John M. Frazier &Kevin T. Geiss [2000], “Biotechnology-A Perspective.” System Management, Vol. 2, .[ 18 ] J. Leslie Glick [1999], “Experimental support for a biotechnology investment strategy.” Technology management:Strategic & Applications , Vol. 5, pp. 111118.[ 19 ] Joseph E. Coombs & David L. Deeds, [2000], “International alliance as sources of capital: evidence from the biotechnology industry.” The journal of high technology management research, Vol. 11, No 2, PP. 235253.[ 20 ] Noel P. Greis and Mark D. Dibner and Alden , [1995], “External partnering as a response to innovation barriers and global petition in biotechnology.” Research Policy, Vol. 24, No. 1, pp. 609630.[ 21 ] Oliver Pfirrmann, [1999]. “Neither soft nor hard-pattern of development of neo technology based firms in biotechnology.” Technovation , Vol. 19, No. 2, pp. 651659 .[ 22 ] Pavitt&Patel, [1988]. “The international distribution and determinants of technological activities.” Oxford Review of Economic Policy, Vol. 4, NO. 4, pp. 3555.[ 23 ] Pisano,. [1990], “The R&D boundaries of the firm:An empirical analysis.” Administrative Science Quarterly Vol. 35, [ 24 ] Susan Bartholomew [1997], “National systems of biotechnology innovation:Complex interdependence in the global system.” Journal of International Business Studies Vol. 28, No. 2, .[ 25 ] Susanne Giesecke [2000], “The contrasting roles of government in the development of biotechnology industry in the US and Germnay .” Reserch Policy Vol. 29, No. 4, .[ 26 ] Weihian Shan&Jaeyong Song [1997], “Foreign direct investment and the sourcing of technological advantage:Evidence from the biotechnology industry.” Journal of International Business Studies Vol. 28, No. 2, .[ 27 ] Shader A. Zahra [1996], “Technology strategy and new venture performance:A study of corporatesponsored and independent biotechnology ventures.” Journal of Business Venturing, Vol. 11, , pp. 289321.35 / 9